ArriVent Share Price
NASDAQ: AVBP | Small Cap | HealthcareArriVent Stock Performance
ArriVent Share Price Today
As of 21 November 2026, ArriVent BioPharma, Inc.'s share price is $10.56. The stock opened at $10.89, compared to its previous close of $11.24. During today's trading session, ArriVent BioPharma, Inc.'s share price traded between $10.39 and $11.27, with an average price of $10.83. Over the past 52 weeks, the stock has recorded a high of $35.59 and a low of $10.39. In terms of performance, ArriVent BioPharma, Inc.'s share price has declined by 65.07% over the last six months and is down 53.97% on a year-on-year basis.
ArriVent Share Price Chart
ArriVent Quarterly Profit & Loss
All figures in USD
ArriVent Annual Profit & Loss
All figures in USD
ArriVent Balance Sheet
All figures in USD Million
ArriVent Cash Flow
All figures in USD Million
About ArriVent
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. The company focuses on advancing its lead product candidate, firmonertinib, for the treatment of epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC), and developing a pipeline of novel therapeutics, including next-generation antibody-drug conjugates such as ARR-217 (MRG007), with an initial focus on solid tumors.
ArriVent Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $14.80 | $10.49 | -29.88% |
Oct 2026 | $30.49 | $14.96 | -50.72% |
Sep 2026 | $30.19 | $30.36 | -2.46% |
Aug 2026 | $30.58 | $31.12 | +4.31% |
Jul 2026 | $34.92 | $29.84 | -14.09% |
Jun 2026 | $29.61 | $34.73 | +14.89% |
May 2026 | $30.96 | $30.23 | -2.80% |
Apr 2026 | $23.41 | $31.10 | +34.63% |
Mar 2026 | $22.79 | $23.10 | +0.20% |
Feb 2026 | $22.10 | $23.05 | +2.49% |
Jan 2026 | $20.47 | $22.50 | +11.75% |
Dec 2025 | $22.09 | $20.13 | -12.25% |